Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
To assess whether neuroprotective drugs administered topically (somatostatin and brimonidine)
are able to prevent or arrest the development and progression of neurodegenerative changes